Bioventus, a medical technology company, will pay millions of dollars to resolve allegations it violated the False Claims Act.
Four things to know:
1. In November 2018, Bioventus disclosed to the OIG that its sales representatives completed Section B of the certificates of medical necessity for its Exogen devices, which should be completed by the physician or physician's office.
2. The company found sales representatives improperly completed some of the forms billed for from Oct. 1, 2012, to Sept. 30, 2018.
3. Bioventus reviewed medical records of the devices used in cases where sales representatives filled out the forms to verify medical necessity.
4. Bioventus agreed to pay more than $3.6 million to resolve the allegations Feb. 25.